Who invested in Neuromed Pharmaceuticals?
Neuromed Pharmaceuticals's investors include BDC Capital, MPM Capital, GrowthWorks, Royal Bank of Canada and MDS Capital, and 2 more on record.
Canada · Series E startup
Funding summaryUpdated 26 Oct 2026
$85Mraised across 2 rounds since 2003, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Neuromed Pharmaceuticals's investors include BDC Capital, MPM Capital, GrowthWorks, Royal Bank of Canada and MDS Capital, and 2 more on record.
Neuromed Pharmaceuticals has raised $85M across 2 rounds since 2003.
Neuromed Pharmaceuticals's most recent round was a Series E of $53M in Aug 2007.
Its most recent round, $53M in Aug 2007, is also its largest on record.
Neuromed Pharmaceuticals's first round on record, in Nov 2003, was backed by BDC Capital, MPM Capital and GrowthWorks and 3 others.
Neuromed Pharmaceuticals's latest named round is a Series E, in Aug 2007.
Neuromed Pharmaceuticals is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.